Cirrhosis Registry of Hospitalized Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Cirrhosis, Liver, Frailty, Ascites, Encephalopathy. Basic parameters: from 19 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Slovakia
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Registry of Adult Consenting Patients Admitted to the Liver Unit With Liver Cirrhosis
Overview
Cirrhosis registry of consecutive adult consenting patients hospitalized with liver cirrhosis in the tertiary liver unit
Detailed description
On admission to F.D.Roosevelt Teaching Hospital / HEGITO Liver Unit (Div Hepatology, Gastroenterology and Liver Transplant), all the adult patients with liver cirrhosis are offered to participate.
After providing informed consent, their demographic, clinical and laboratory / imaging data are uploaded by dedicated study person After discharge from the hospital, follow-up is recommended and uploaded to RH7 (if the follow-up visits take place at this institution \[FDR\]) Mortality data are uploaded from the national registry of dead on regular basis
Primary outcome measures
- Frequency and type of decompensation of liver cirrhosis [Time frame: "1 year"]
- Mortality [Time frame: "1 year"]
Secondary outcome measures (3)
- Mortality [Time frame: 90-day]
- Mortality [Time frame: 1 year]
- Frailty [Time frame: On admission]
Eligibility criteria
Inclusion criteria
- liver cirrhosis (primarily on clinical grounds)
- decompensating event leading to hospital admission
- informed consent
Exclusion criteria
- declined consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Slovakia · 1 center
- F.D.Roosevelt Teaching Hospital — Banská Bystrica
Publications
- Koller T, Vrbova P, Kubanek N, Zilincanova D, Selcanova SA, Havaj DJ, Skladany L. Assessment of intestinal inflammation via fecal calprotectin for early prediction of adverse outcomes in advanced chronic liver disease. United European Gastroenterol J. 2025 Apr;13(3):305-316. doi: 10.1002/ueg2.12633. Epub 2024 Jul 19. PMID 39031494
Identifiers
NCT: NCT04767945 · HEGITO2014